14 completed, 6 unknown, 2 active not recruiting, 2 recruiting. 6 Not applicable, 5 Phase 3, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Unknown 3, Completed 2, Recruiting 1 |
| Phase 3 | 5 | Active not recruiting 2, Completed 2, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow University of Heidelberg Medical Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GMMG-HD11/DSMM XXI/64007957MMY3010 Teclistamab, Daratumumab, Lenalidomide - Multiple Myeloma | Phase 3 | Not yet recruiting | University of Heidelberg Medical Center | 399 | 2026-06-30 | 2026-06-26 |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma Iberdomide, Isatuximab, Dexamethasone - Multiple Myeloma | Phase 3 | Active not recruiting | University of Heidelberg Medical Center | 411 | 2024-04-05 | 2026-08-17 |
| Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma Isatuximab, Lenalidomide, Bortezomib - Multiple Myeloma | Phase 3 | Completed | University of Heidelberg Medical Center | 514 | 2023-04-14 | 2026-02-18 |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 Teclistamab (Tec), Daratumumab, Dexamethasone - Multiple Myeloma | Phase 2 | Recruiting | University of Heidelberg Medical Center | 160 | 2022-12-01 | 2025-12-24 |
| Neural Correlates of Sensory Specific Satiety Satiety Response, Functional Neuroimaging | Completed | University of Heidelberg Medical Center | 30 | 2022-02-01 | 2023-11-29 | |
| Investigating Neuronal and Peripheral Markers of Brain Heart Interaction in Healthy Participants Under Stress Heart Rate, Magnetic Resonance Imaging | Completed | University of Heidelberg Medical Center | 25 | 2022-02-01 | 2023-11-29 | |
| Endocrinological and Neuronal Aspects of Bariatric Surgery bariatric surgery, conservative diet - Bariatric Surgery, Obesity | Unknown | University of Heidelberg Medical Center | 60 | 2020-12-01 | 2023-01-13 | |
| Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder fmri - Food Habits, Binge-Eating Disorder | Completed | University of Heidelberg Medical Center | 31 | 2019-09-01 | 2023-01-13 | |
| Home HIV Testing for Older Adults in South Africa Home HIV self-testing, Home HIV rapid testing, Home HIV self-testing and rapid testing - HIV Infections, Knowledge, Attitudes, Practice | Not applicable | Unknown | Harvard School of Public Health (HSPH) | 3578 | 2019-05-15 | 2020-02-21 |
| Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7) Lenalidomide, Bortezomib, Dexamethasone - Multiple Myeloma | Phase 3 | Active not recruiting | University of Heidelberg Medical Center | 662 | 2018-10-18 | 2026-02-03 |
| ZIKAlliance Natural History Study Zika Virus, Zika Virus Infection | Withdrawn | University of Heidelberg Medical Center | 2018-04-01 | 2022-05-18 | ||
| ZIKAlliance Children Cohort (ZIKAllianceCH) Zika Virus | Completed | University of Heidelberg Medical Center | 1554 | 2018-01-15 | 2022-05-18 | |
| Evaluation of Optical Coherence Tomography in Dentistry Transbond XT, Protecto®CaF2Nano, Pro Seal® - Dental Caries, Tooth Demineralization | Not applicable | Recruiting | University of Heidelberg Medical Center | 20 | 2017-12-04 | 2018-11-28 |
| ZIKAlliance Pregnant Women Cohort Zika Virus, Pregnancy Related | Completed | University of Heidelberg Medical Center | 3852 | 2017-05-24 | 2022-05-24 | |
| BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA) Encorafenib, Binimetinib - Relapsed or Refractory Multiple Myeloma, Patients With BRAFV600 E or BRAFV600K Mutation | Phase 2 | Completed | University of Heidelberg Medical Center | 12 | 2016-06-01 | 2023-11-24 |
| Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease Colorectal Cancer, Breast Cancer | Completed | Heidelberg University | 2200 | 2015-12-01 | 2023-02-16 | |
| Food Reward Processing in the Human Brain Satiety State - Healthy | Completed | University of Heidelberg Medical Center | 23 | 2015-06-09 | 2022-03-29 | |
| A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma elotuzumab, Lenalidomide, Bortezomib - Multiple Myeloma | Phase 3 | Completed | University of Heidelberg Medical Center | 564 | 2015-06-01 | 2021-09-10 |
| Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa Glucose, Placebo - Anorexia Nervosa, Healthy | Not applicable | Completed | University of Heidelberg Medical Center | 85 | 2014-09-01 | 2019-10-03 |
| Treatment Efficiency of Acupuncture in Non Chronified Pain Patients With TMDs acupuncture - Temporomandibular Disorders | Not applicable | Unknown | University of Heidelberg Medical Center | 40 | 2014-04-01 | 2016-02-03 |
Showing 20 of 26. Sign in to see all of them.
Multiple Myeloma (7) · Dengue (3) · Zika Virus Infection (3) · Chikungunya Fever (2) · Obesity (2) · Anorexia Nervosa (1) · Behavior (1) · Binge-Eating Disorder (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Dental Caries (1) · Dyslexia (1) · Fasting (1) · Feeding Behavior (1) · HIV Infections (1)
Bortezomib (5) · Dexamethasone (5) · Lenalidomide (5) · isatuximab (3) · daratumumab (2) · Acupuncture Therapy (1) · Bariatric Surgery (1) · CYFIP2 protein, human (1) · Cetuximab (1) · Focal Adhesion Protein-Tyrosine Kinases (1) · Glucose (1) · Observation (1) · Radiotherapy, Intensity-Modulated (1) · binimetinib (1) · elotuzumab (1)
Germany (17) · Brazil (4) · Venezuela (3) · Austria (2) · Bolivia (2) · Colombia (2) · Cuba (2) · Guadeloupe (2) · Mexico (2) · Bangladesh (1) · Cambodia (1) · El Salvador (1) · Indonesia (1) · Malaysia (1) · South Africa (1)
Hartmut Goldschmidt, Prof. (2) · Hartmut Goldschmidt, Prof. Dr. (2) · Joe Simon, Dr. Dipl. Psych. (2) · Adrian Billeter, PD, MD (1) · Andreas A Schnitzbauer, MD (1) · Christian Templin, MD, PhD (1) · Joachim Pietz, Prof. Dr. (1) · Joachim Wiskemann, Dr. (1) · Karen G Steindorf, Prof. Dr. (1) · Karen Steindorf, Prof. Dr. (1) · Marc S Raab, Prof. Dr. med (1) · Marc S. Raab, PD Dr. med. (1) · Monika Sieverding, Prof. Dr. (1)
PMID 31878895, PMID 37990162, PMID 1298767, PMID 21228118, PMID 23816330, PMID 23855804, PMID 25748465, PMID 26168856, PMID 26312977, PMID 26332547, PMID 26419674, PMID 26968374, PMID 27412903, PMID 27928880, PMID 28768906, PMID 28818208, PMID 29406443, PMID 29517122, PMID 30115226, PMID 30589829, PMID 30819368, PMID 30983543, PMID 31138244, PMID 31311438, PMID 31672100, PMID 31765473, PMID 31766870, PMID 31863563, PMID 31931900, PMID 32484517, PMID 32789656, PMID 33253318, PMID 34013386, PMID 34165180, PMID 34315238, PMID 34404907, PMID 34550527, PMID 34876622, PMID 35599349, PMID 36328040, PMID 36608320, PMID 38062124, PMID 38194610, PMID 38302221, PMID 39606939, PMID 39652594, PMID 41611312, PMID 42166704, PMID 42350642, PMID 42670759
2014 (1), 2025 (1)